Src inhibition modulates AMBRA1‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis.

MLA

Gui, Zeping, et al. “Src Inhibition Modulates AMBRA1‐mediated Mitophagy to Counteract Endothelial‐to‐mesenchymal Transition in Renal Allograft Fibrosis.” Cell Proliferation, vol. 57, no. 11, Nov. 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1111/cpr.13699.

APA

Gui, Z., Liu, X., Xu, Z., Feng, D., Hang, Z., Zheng, M., Chen, H., Fei, S., Sun, L., Tao, J., Han, Z., Ju, X., Gu, M., Tan, R., & Wang, Z. (2024). Src inhibition modulates AMBRA1‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis. Cell Proliferation, 57(11), 1–20. https://doi.org/10.1111/cpr.13699

Chicago

Gui, Zeping, Xuzhong Liu, Zhen Xu, Dengyuan Feng, Zhou Hang, Ming Zheng, Hao Chen, et al. 2024. “Src Inhibition Modulates AMBRA1‐mediated Mitophagy to Counteract Endothelial‐to‐mesenchymal Transition in Renal Allograft Fibrosis.” Cell Proliferation 57 (11): 1–20. doi:10.1111/cpr.13699.